Our results suggest that polymorphism in SLC30A10 is a risk factor for manganese-induced hepatocellular damage, polycythemia, and iron anemia in a much broader population beyond the rare recessive syndrome HMNDYT1. Here, SLC30A10 is linked to polycythemia.